Finanzwire Finanzwire
Basculer en Français
11091 Companies
243698 Keywords
171802 Articles
131261 Press releases
Headlines Articles Press releases CYPRUMED GmbH Remove
  1. Home
  2. Companies
  3. CYPRUMED GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/29/2026 at 10:05, 1 hour 58 minutes ago

    Cyprumed's Oral Delivery Technology Enters Clinical Phase with MSD Trial

    Clinical Development Phase I Trial Cyprumed Oral Delivery Technology MSD Collaboration
  • PRESS RELEASE

    published on 09/29/2026 at 10:00, 2 hours 3 minutes ago

    Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial

    Cyprumed's oral delivery technology advances to clinical stage as MSD initiates Phase I trial, marking a significant milestone in drug development
    Phase I Trial Clinical Stage Cyprumed MSD Oral Delivery Technology
    Logo of CYPRUMED GmbH
  • BRIEF

    published on 04/15/2025 at 09:05, 1 year 5 months ago

    Cyprumed Partners with MSD on Oral Peptide Therapeutics

    Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
  • PRESS RELEASE

    published on 04/15/2025 at 09:00, 1 year 5 months ago

    Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

    Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics
    Drug Delivery Technology License Agreement Cyprumed Oral Peptide Therapeutics MSD
    Logo of CYPRUMED GmbH
Accesswire
  • Published on 09/29/2026 at 12:00, 3 minutes ago

    Blue Lagoon Starts Drilling at Dome Mountain Gold Mine

  • Published on 09/29/2026 at 10:30, 1 hour 33 minutes ago

    Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting

  • Published on 09/29/2026 at 09:01, 3 hours 2 minutes ago

    Star Copper Advances Western Extension Drilling at Star Main

  • Published on 09/29/2026 at 06:45, 5 hours 18 minutes ago

    Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries

  • Published on 09/29/2026 at 04:36, 7 hours 27 minutes ago

    The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)

View all ACCESSWIRE
EQS Group
  • Published on 09/29/2026 at 11:55, 8 minutes ago

    Solavita Sets a New Strategic Direction as a Smart Microgrid Expert for Diverse Energy Scenarios

  • Published on 09/29/2026 at 11:30, 33 minutes ago

    Huawei Launches Intelligent RAIL 2.0 to Accelerate Global Railway Intelligence Upgrade

  • Published on 09/29/2026 at 11:15, 47 minutes ago

    EQS-Adhoc: Nakiki SE: NAKIKI SE acquires 9.749% of ecrop GmbH

  • Published on 09/29/2026 at 11:05, 58 minutes ago

    Furniture China and Maison Shanghai 2026 Conclude on a High Note in Pudong, Shanghai

  • Published on 09/29/2026 at 10:05, 1 hour 58 minutes ago

    LionVolt opens Flight One early access to UAV OEMs

View all EQS
Les Echos
  • Published on 09/28/2026 at 17:54, 18 hours 8 minutes ago

    Reporting on share buyback transactions carried out between September 21 and September 25, 2026

  • Published on 09/28/2026 at 17:45, 18 hours 18 minutes ago

    Weekly share buyback

  • Published on 09/28/2026 at 17:35, 18 hours 28 minutes ago

    Disclosure of transactions in own shares from September 21 to September 25, 2026

  • Published on 09/28/2026 at 08:45, 1 day 3 hours ago

    BAIKOWSKI: 2026 first-half results

  • Published on 09/28/2026 at 08:02, 1 day 4 hours ago

    Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy